Literature DB >> 29406377

Survey of Bedside Clinical Neurologic Assessments in U.S. PICUs.

Matthew P Kirschen1,2,3, Megan Snyder4, Madeline Winters4, Rebecca Ichord2,3, Robert A Berg1,3, Vinay Nadkarni1,3, Alexis Topjian1,3.   

Abstract

OBJECTIVE: To understand how routine bedside clinical neurologic assessments are performed in U.S. PICUs.
DESIGN: Electronic survey.
SETTING: Academic PICUs throughout the United States.
SUBJECTS: Faculty representatives from PICUs throughout the United States.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We surveyed how routine bedside neurologic assessments are reported to be performed in U.S. PICUs and the attitudes of respondents on the utility of these assessments. The survey contained questions regarding 1) components of neurologic assessments; 2) frequency of neurologic assessments; 3) documentation and communication of changes in neurologic assessment; and 4) optimization of neurologic assessments. Surveys were received from 64 of 67 institutions (96%). Glasgow Coma Scale and pupillary reflex were the most commonly reported assessments (80% and 92% of institutions, respectively). For patients with acute brain injury, 95% of institutions performed neurologic assessments hourly although assessment frequency was more variable for patients at low risk of developing brain injury and those at high risk for brain injury, but without overt injury. In 73% of institutions, any change detected on routine neuroassessment was communicated to providers, whereas in 27%, communication depended on the severity or degree of neurologic decline. Seventy percent of respondents thought that their current practice for assessing and monitoring neurologic status was suboptimal. Only 57% felt that the Glasgow Coma Scale was a valuable tool for the serial assessment of neurologic function in the ICU. Ninety-two percent felt that a standardized approach to assessing and documenting preillness neurologic function would be valuable.
CONCLUSIONS: Routine neurologic assessments are reported to be conducted in nearly all academic PICUs in the United States with fellowship training programs although the content, frequency, and triggers for communication vary between institutions. Most physicians felt that the current paradigms for neurologic assessments are suboptimal. These data suggest that optimizing and standardizing routine bedside nursing neurologic assessments may be warranted.

Entities:  

Mesh:

Year:  2018        PMID: 29406377      PMCID: PMC6175815          DOI: 10.1097/PCC.0000000000001463

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  26 in total

1.  The Glasgow Coma Scale: time for critical reappraisal?

Authors:  Steven Laureys; Olivier Bodart; Olivia Gosseries
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

2.  Validation of a new coma scale: The FOUR score.

Authors:  Eelco F M Wijdicks; William R Bamlet; Boby V Maramattom; Edward M Manno; Robyn L McClelland
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

3.  Improving the Glasgow Coma Scale score: motor score alone is a better predictor.

Authors:  C Healey; Turner M Osler; Frederick B Rogers; Mark A Healey; Laurent G Glance; Patrick D Kilgo; Steven R Shackford; J Wayne Meredith
Journal:  J Trauma       Date:  2003-04

4.  Assessing the outcome of pediatric intensive care.

Authors:  D H Fiser
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

5.  International Survey of Critically Ill Children With Acute Neurologic Insults: The Prevalence of Acute Critical Neurological Disease in Children: A Global Epidemiological Assessment Study.

Authors:  Ericka L Fink; Patrick M Kochanek; Robert C Tasker; John Beca; Michael J Bell; Robert S B Clark; Jamie Hutchison; Monica S Vavilala; Anthony Fabio; Derek C Angus; R Scott Watson
Journal:  Pediatr Crit Care Med       Date:  2017-04       Impact factor: 3.624

6.  A pediatric FOUR score coma scale: interrater reliability and predictive validity.

Authors:  Brianna L Czaikowski; Hong Liang; C Todd Stewart
Journal:  J Neurosci Nurs       Date:  2014-04       Impact factor: 1.230

7.  Assessment and prognosis of coma after head injury.

Authors:  G Teasdale; B Jennett
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

8.  The motor response to stimulation predicts outcome as well as the full Glasgow Coma Scale in children with severe head injury.

Authors:  Peter-Marc Fortune; Frank Shann
Journal:  Pediatr Crit Care Med       Date:  2010-05       Impact factor: 3.624

Review 9.  Paediatric coma scales.

Authors:  Fenella J Kirkham; Charles R J C Newton; William Whitehouse
Journal:  Dev Med Child Neurol       Date:  2008-02-27       Impact factor: 5.449

10.  Lack of Standardization in the Use of the Glasgow Coma Scale: Results of International Surveys.

Authors:  Florence C M Reith; Paul M Brennan; Andrew I R Maas; Graham M Teasdale
Journal:  J Neurotrauma       Date:  2015-08-12       Impact factor: 5.269

View more
  3 in total

1.  Pediatric Neurocritical Care and Neuromonitoring in 2018-Maybe We Need to Go Back to the Basics?

Authors:  Anita Patel; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2018-04       Impact factor: 3.624

2.  Identification of Pediatric Sepsis for Epidemiologic Surveillance Using Electronic Clinical Data.

Authors:  Scott L Weiss; Fran Balamuth; Marianne Chilutti; Mark Jason Ramos; Peter McBride; Nancy-Ann Kelly; K Joy Payton; Julie C Fitzgerald; Jeffrey W Pennington
Journal:  Pediatr Crit Care Med       Date:  2020-02       Impact factor: 3.624

Review 3.  The brain in pediatric critical care: unique aspects of assessment, monitoring, investigations, and follow-up.

Authors:  Kate L Brown; Shruti Agrawal; Matthew P Kirschen; Chani Traube; Alexis Topjian; Ronit Pressler; Cecil D Hahn; Barnaby R Scholefield; Hari Krishnan Kanthimathinathan; Aparna Hoskote; Felice D'Arco; Melania Bembea; Joseph C Manning; Maayke Hunfeld; Corinne Buysse; Robert C Tasker
Journal:  Intensive Care Med       Date:  2022-04-21       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.